X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

SNGX

Closed

Soligenix Inc

1.41
+0.10 (+7.63%)
Last Update: 01 Jul 2025 23:29:00
Yesterday: 1.31
Day's Range: 1.31 - 1.88
Send
When Written:
 
1.63
Soligenix Inc is a biopharmaceutical company that develops and commercializes products for rare diseases and unmet medical needs. The company's lead product candidates include SGX301, a photodynamic therapy for the treatment of cutaneous T-cell lymphoma; SGX942, a treatment for oral mucositis in head and neck cancer patients; and RiVax, a vaccine for ricin toxin exposure. Soligenix also has a proprietary vaccine adjuvant technology called ThermoVax, which is designed to enhance the efficacy of vaccines. The company was founded in 1987 and is headquartered in Princeton, New Jersey.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X